Breaking News

Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to testify on drug pricing; Prominent pharmaceutical industry ally Anna Eshoo to retire 

November 21, 2023
Pharmalot Columnist, Senior Writer
Sen. Bernie Sanders is teeing up yet another hearing with pharmaceutical executives on drug pricing.
Kevin Dietsch/Getty Images

STAT+ | Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to testify on drug pricing

All three companies have sued the Biden administration over the new Medicare drug price negotiation that Democrats passed last year.

By Rachel Cohrs


STAT+ | Prominent pharmaceutical industry ally Anna Eshoo to retire

Eshoo's retirement will be yet another loss of a Democratic champion for the pharmaceutical industry next election cycle.

By Rachel Cohrs and John Wilkerson


STAT+ | Flagship Pioneering launches Quotient, a new biotech, in two countries

Quotient Therapeutics wants to develop drugs that target illnesses caused by genetic changes that occur as people age.

By Jonathan Saltzman — Boston Globe



Adobe

STAT+ | Mixed study results for MorphoSys blood-cancer drug raise questions about approval

Mixed study results for Morphosys blood-cancer drug raise questions about approval

By Andrew Joseph and Adam Feuerstein


Opinion: Filling 12-month prescriptions is one practical way to help the pharmacist crisis

Getting a year's worth of a maintenance medication in one visit makes life easier for both pharmacists and patients.

By Stephen Buck


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Pharmalot? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments